Showing results (261-270 of 764) with videos related to
Sort By:
Pageof 77
Research in Veterinary Science|December 17, 2009
In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative studyJ N King, C Rudaz, L Borer, et al.Journal of Veterinary Pharmacology and Therapeutics|April 2, 2003
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine bloodK J Rickards, C P Page, P Lees, et al.Veterinary Journal (London, England : 1997)|March 6, 2003
Ketoprofen in the cat: pharmacodynamics and chiral pharmacokineticsP Lees, P M Taylor, F M Landoni, et al.Methods in Molecular Biology (Clifton, N.J.)|January 4, 2007
Utilizing protein phosphatase inhibitors to define PP2A as a regulator of ataxia-telangiectasia mutatedAaron A Goodarzi, Pauline Douglas, Greg B G Moorhead, et al.Journal of Veterinary Pharmacology and Therapeutics|June 1, 1996
A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary diseaseK A Marr, S M Fairbairn, C P Page, et al.Journal of Veterinary Pharmacology and Therapeutics|March 18, 2014
Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammationL Pelligand, J N King, V Hormazabal, et al.The Journal of Pharmacology and Experimental Therapeutics|May 11, 2012
Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643Serdar Durdagi, Jiqing Guo, James P Lees-Miller, et al.The Veterinary Record|August 13, 2017
Comparison of veterinary drugs and veterinary homeopathy: part 1P Lees, L Pelligand, M Whiting, et al.Equine Veterinary Journal|November 5, 1997
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary diseaseJ M Ablett, S M Fairbairn, C P Page, et al.Journal of Veterinary Pharmacology and Therapeutics|January 24, 2009
Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxibJ M Giraudel, J N King, E C Jeunesse, et al.Pageof 77